CN108096416A - 一种禽用抗支气管炎病毒的组合物、冻干粉及制备方法 - Google Patents
一种禽用抗支气管炎病毒的组合物、冻干粉及制备方法 Download PDFInfo
- Publication number
- CN108096416A CN108096416A CN201711292002.2A CN201711292002A CN108096416A CN 108096416 A CN108096416 A CN 108096416A CN 201711292002 A CN201711292002 A CN 201711292002A CN 108096416 A CN108096416 A CN 108096416A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- fowl
- bronchitis virus
- freeze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 46
- 206010006451 bronchitis Diseases 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 9
- 239000000843 powder Substances 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 title claims description 12
- 239000000284 extract Substances 0.000 claims abstract description 83
- 229940107666 astragalus root Drugs 0.000 claims abstract description 15
- 238000000605 extraction Methods 0.000 claims abstract description 15
- 241000287828 Gallus gallus Species 0.000 claims abstract description 12
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000950640 Calcarius Species 0.000 claims abstract description 8
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 8
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 8
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 8
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 8
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 8
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 8
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 8
- 241000334160 Isatis Species 0.000 claims abstract description 7
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 7
- 235000020696 epimedium extract Nutrition 0.000 claims abstract description 7
- 244000248825 Peltandra virginica Species 0.000 claims abstract 4
- 239000000243 solution Substances 0.000 claims description 34
- 210000002969 egg yolk Anatomy 0.000 claims description 29
- 230000000840 anti-viral effect Effects 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 22
- 108010074506 Transfer Factor Proteins 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 12
- 229960005486 vaccine Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 238000004113 cell culture Methods 0.000 claims description 9
- 235000013601 eggs Nutrition 0.000 claims description 9
- 210000004989 spleen cell Anatomy 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- 208000010359 Newcastle Disease Diseases 0.000 claims description 6
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 claims description 6
- 229960003556 aminophylline Drugs 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 5
- 102000002322 Egg Proteins Human genes 0.000 claims description 4
- 108010000912 Egg Proteins Proteins 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 4
- 239000002504 physiological saline solution Substances 0.000 claims description 4
- 244000144977 poultry Species 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 claims description 4
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 3
- 239000012930 cell culture fluid Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000013345 egg yolk Nutrition 0.000 claims description 3
- 210000003743 erythrocyte Anatomy 0.000 claims description 3
- 210000003722 extracellular fluid Anatomy 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 244000144992 flock Species 0.000 claims description 3
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 claims description 3
- 229940124736 hepatitis-B vaccine Drugs 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 230000000937 inactivator Effects 0.000 claims description 3
- 238000005360 mashing Methods 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000003223 protective agent Substances 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 210000000952 spleen Anatomy 0.000 claims description 3
- 239000008223 sterile water Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000008399 tap water Substances 0.000 claims description 3
- 235000020679 tap water Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 210000004681 ovum Anatomy 0.000 claims 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims 1
- 235000021286 stilbenes Nutrition 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 230000000903 blocking effect Effects 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 description 7
- 244000197580 Poria cocos Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000271566 Aves Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000000155 melt Substances 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种禽用抗支气管炎病毒的组合物,包括黄芪提取物1.2份,人参提取物1.5份、茯苓提取物1.7份,黄芪提取物1.8份,当归提取物1.5份,山药提取物2份,菊花提取物1.8份,淫羊霍提取物1.5份,大青叶提取物1.2份,黄连提取物1.2份,板蓝根提取物1.2份,麻黄提取物1.3份,白芍提取物1.1份,细辛提取物1.2份,五味子提取物1.3份。本发明采用黄芪提取物,人参提取物、茯苓提取物,黄芪提取物,当归提取物,白芍提取物提取物,细辛提取物提取物,五味子提取物是精选的采用对支气管炎病毒有阻断作用的药材,同时这些提取物也能够对受损后的细胞进行修复。能够有效治愈传染支气管炎病毒传播,增强鸡的免疫力。
Description
技术领域
本发明涉及一种养殖技术领域,特别是涉及一种禽用抗支气管炎病毒的组合物、冻干粉及制备方法。
背景技术
病毒感染是一大类严重威胁禽畜健康的疾病,然而现在由于疫苗和抗病毒西药的广泛使用,导致很多类型的病毒发生了抗药性,禽类支气管炎是由支气管病毒引发的一种能够高度传染的呼吸道疾病,其为养殖过程带来较大的经济损失,实践中,通常采用提前接种疫苗或者西药完成预防病害的效果,但是这样容易使禽类产生抗药性,进而对消费者健康产生影响,现有技术中,缺少一种能够抗支气管炎病毒同时避免病毒产生抗药性的药物,使得能够安全地对抗支气管炎病毒进行防治。
因此本领域技术人员致力于开发一种能够抗病毒同时避免病毒产生抗药性的药物,使得能够安全地对抗支气管炎病毒进行防治。
发明内容
有鉴于现有技术的上述缺陷,本发明所要解决的技术问题是提供一种能够抗病毒同时避免病毒产生抗药性的药物,使得能够安全地对抗支气管炎病毒进行防治。
为实现上述目的,本发明提供了一种禽用抗支气管炎病毒的组合物,冻干粉、冻干粉的制备方法、及所述冻干粉作为饲料添加剂的应用,包括黄芪提取物1.2份,人参提取物1.5份、茯苓提取物1.7份,黄芪提取物1.8份,当归提取物1.5份,山药提取物2份,菊花提取物1.8份,淫羊霍提取物1.5份,大青叶提取物1.2份,黄连提取物1.2份,板蓝根提取物1.2份,麻黄提取物1.3份,白芍提取物1.1份,细辛提取物1.2份,五味子提取物1.3份。还包括禽用抗病毒卵黄抗体,禽用抗病毒转移因子1.8份和α-干扰素1.2份。所述禽用抗病毒卵黄抗体为抗鸡新城疫卵黄抗体,所述禽用抗病毒转移因子为抗鸡新城疫转移因子。
一种禽用抗支气管炎病毒的冻干粉,主要由以下重量份数的组分组成:黄芪提取物1.2份,人参提取物1.5份、茯苓提取物1.7份,黄芪提取物1.8份,当归提取物1.5份,山药提取物2份,菊花提取物1.8份,淫羊霍提取物1.5份,大青叶提取物1.2份,黄连提取物1.2份,板蓝根提取物1.2份,麻黄提取物1.3份,白芍提取物1.1份,细辛提取物1.2份,五味子提取物1.3份。
本发明通过选择这数10种中药材来进行禽用抗支气管炎的防治,是由于这10种中药材均具有提高禽体免疫能力的作用,同时能够有效抑制禽类支气管炎病毒。
这些药材均属于常见药材,可以通过在药材市场上购买取得。
较优的,还包括以下重量份数的组分:禽用抗病毒卵黄抗体70-80份,禽用抗病毒转移因子1.8份和α-干扰素1.2份。
较优的,还包括氨茶碱1.8份。
较优的,包括链霉素1份和以重量份计0.05%的多维生素。
一种禽用抗支气管炎病毒的冻干粉制备方法,包括以下步骤:
(1)分离毒株制备疫苗,灭活后制得乳油剂疫苗备用;
(2)中药提取液的制备:按照如权利要求1所述的重量配比,取相同份数的中药材,采用常规水煎制备所述中药材的提取液;
(3)将步骤(2)中的中药材提取液进行浓缩,浓缩至1g/ml的药液;
(4)将步骤(3)中的药液进行3000r/ml进行离心,离心20min,得上清液;
(5)将步骤(4)中的药液用0.22μm进行微孔滤膜过滤,高压蒸汽灭菌,4℃冷藏备用;
(6)免疫健康鸡群制备高免蛋:取步骤(1)制备的疫苗接种健康鸡群,当抗体效价达到1:256时,收集高免蛋清理、消毒后晾干备用;
(7)分离高免蛋卵黄:取步骤(6)制备的高免蛋分离卵黄,加入等体积的无菌水,充分搅拌至颜色发白的卵黄溶液,将卵黄溶液置于60-65℃的水浴中加热20min。再加入PH为4.9-5.2的预冷酸化水,加入量为卵黄溶液体积的6-8倍,混匀后室温下静置沉淀,取得上清液后离心分离;
(8)取步骤(7)离心后的上清液,过滤,使得滤液中禽用抗病毒卵黄抗体的干重为70-80份,在浓缩液中加入步骤(5)的灭菌药液,再加入氨茶碱1.8份,防腐剂0.01份,灭活剂0.2份,链霉素1份,耐热冻干保护剂3份,0.05%的维生素1份,混匀后预冻、冻干备用;
(9)以重量份数剂,在步骤(8)的干粉中加入禽用抗病毒转移因子1.8份和α-干扰素1.2份即可。
较优的,所述禽用抗支气管炎病毒转移因子的制备方法为:
(1)取刚屠宰的新鲜健康猪脾,用生理盐水反复冲洗后灭菌并去膜、脂肪、筋等;
(2)组织捣碎机以5000r/min的速度进行捣碎,共3次,每次间隔5min;
(3)冷却捣碎机,冷却后的细胞培养液以1500r/min的速度离心10min;
(4)去除离心液的上清液,续加氯化铵液,离心并去红细胞;
(5)利用小牛血清培养液制成猪脾细胞培养液;
(6)取步骤(5)中的猪脾细胞培养液100μl,加入质量浓度为100g/L的乙肝疫苗100μl;
(7)取步骤(6)中的猪脾细胞培养液,加入质量浓度为20g/L的支气管炎病毒疫苗50μl;
(8)将步骤(7)中的培养液加入蒸馏水1:1稀释,-25℃反复冻融6次,自来水融化后装入透析袋中;
(9)用1:4蒸馏水作为透析外液,4℃透析48h,取得透析液,4℃保存或冻干备用。
本发明中采用体外制备抗病因子的方法,比现有方法活体接疫苗后提取组织液的方法而言,其制备更具有经济性,且更容易制备,制备的抗病因子纯度也更高。
较优的,一种禽用抗支气管炎病毒冻干粉作为饲料添加剂的应用,包括以下步骤,将禽用抗支气管炎病毒冻干粉以1.2%的量加入禽用饲料中即可。
本发明的有益效果是:本发明采用黄芪提取物,人参提取物、茯苓提取物,黄芪提取物,当归提取物,山药提取物,菊花提取物,淫羊霍提取物,大青叶提取物,黄连提取物,板蓝根提取物,麻黄提取物,白芍提取物提取物,细辛提取物提取物,五味子提取物是精选的采用对支气管炎病毒有阻断作用的药材,同时这些提取物也能够对受损后的细胞进行修复。能够有效治愈传染支气管炎病毒传播,增强禽类的免疫力。
具体实施方式
下面结合实施例对本发明作进一步说明:
实施例1,一种禽用抗支气管炎病毒的组合物,包括黄芪提取物1.2份,人参提取物1.5份、茯苓提取物1.7份,黄芪提取物1.8份,当归提取物1.5份,山药提取物2份,菊花提取物1.8份,淫羊霍提取物1.5份,大青叶提取物1.2份,黄连提取物1.2份,板蓝根提取物1.2份,麻黄提取物1.3份,白芍提取物1.1份,细辛提取物1.2份,五味子提取物1.3份。
还包括禽用抗病毒卵黄抗体,禽用抗病毒转移因子1.8份和α-干扰素1.2份。禽用抗病毒卵黄抗体为抗鸡新城疫卵黄抗体,禽用抗病毒转移因子为抗鸡新城疫转移因子。
主要由以下重量份数的组分组成:黄芪提取物1.2份,人参提取物1.5份、茯苓提取物1.7份,黄芪提取物1.8份,当归提取物1.5份,山药提取物2份,菊花提取物1.8份,淫羊霍提取物1.5份,大青叶提取物1.2份,黄连提取物1.2份,板蓝根提取物1.2份,麻黄提取物1.3份,白芍提取物1.1份,细辛提取物1.2份,五味子提取物1.3份。
还包括以下重量份数的组分:禽用抗病毒卵黄抗体,禽用抗病毒转移因子80份和α-干扰素1.2份。还包括氨茶碱1.8份。
包括链霉素1份和以重量份计0.05%的多维生素。
本实施例中采用以下步骤来制备禽用抗支气管炎病毒的冻干粉制备方法,包括以下步骤:
(1)分离毒株制备疫苗,灭活后制得乳油剂疫苗备用;
(2)中药提取液的制备:按照如权利要求1的重量配比,取相同份数的中药材,采用常规水煎制备中药材的提取液;
(3)将步骤(2)中的中药材提取液进行浓缩,浓缩至1g/ml的药液;
(4)将步骤(3)中的药液进行3000r/ml进行离心,离心20min,得上清液;
(5)将步骤(4)中的药液用0.22μm进行微孔滤膜过滤,高压蒸汽灭菌,4℃冷藏备用;
(6)免疫健康鸡群制备高免蛋:取步骤(1)制备的疫苗接种健康鸡群,当抗体效价达到1:256时,收集高免蛋清理、消毒后晾干备用;
(7)分离高免蛋卵黄:取步骤(6)制备的高免蛋分离卵黄,加入等体积的无菌水,充分搅拌至颜色发白的卵黄溶液,将卵黄溶液置于60-65℃的水浴中加热20min。再加入PH为5.2的预冷酸化水,加入量为卵黄溶液体积的6.8倍,混匀后室温下静置沉淀,取得上清液后离心分离;(8)取步骤(7)离心后的上清液,过滤,使得滤液中禽用抗病毒卵黄抗体的干重为50-60份,在浓缩液中加入步骤(5)的灭菌药液,再加入氨茶碱1.8份,防腐剂0.01份,灭活剂0.2份,链霉素1份,耐热冻干保护剂3份,0.05%的维生素1份,混匀后预冻、冻干备用;(9)以重量份数剂,在步骤(8)的干粉中加入禽用抗病毒转移因子1.8份和α-干扰素1.2份即可。
一种禽用抗支气管炎病毒的冻干粉制备方法,禽用抗支气管炎病毒转移因子的制备方法为:
(1)取刚屠宰的新鲜健康猪脾,用生理盐水反复冲洗后灭菌并去膜、脂肪、筋等;
(2)组织捣碎机以5000r/min的速度进行捣碎,共3次,每次间隔5min;
(3)冷却捣碎机,冷却后的细胞培养液以1500r/min的速度离心10min;
(4)去除离心液的上清液,续加氯化铵液,离心并去红细胞;
(5)利用小牛血清培养液制成猪脾细胞培养液;
(6)取步骤(5)中的猪脾细胞培养液100μl,加入质量浓度为100g/L的乙肝疫苗100μl;
(7)取步骤(6)中的猪脾细胞培养液,加入质量浓度为20g/L的支气管炎病毒疫苗50μl;
(8)将步骤(7)中的培养液加入蒸馏水1:1稀释,-25℃反复冻融6次,自来水融化后装入透析袋中;
(9)用1:4蒸馏水作为透析外液,4℃透析48h,取得透析液,4℃保存或冻干备用。
一种禽用抗支气管炎病毒冻干粉作为饲料添加剂的应用,包括以下步骤,将禽用抗支气管炎病毒冻干粉以1.2%的量加入禽用饲料中即可。
试验方法:选取1月龄鸡200只,其中100只作为攻毒组隔离饲养,100只作为空白对照组隔离饲养,100作为试验组按照本发明的方式进行饲养,试验组采用实施例1制备的冻干粉,饲养方式为自由采食,自由饮水,24h后取试验组、对照组和攻毒组的鸡肌注接种稀释后的鸡支气管炎病毒液,感染后继续饲养,治疗时对照组和试验组每100ml注射液中分别含有冻干粉1g,采用肌注方式给药,0.1ml/kg体重,每日2次,攻毒组肌注生理盐水,用法同上,120h后得到表1结果如下:
组别 | 病鸡数/只 | 治愈数/只 | 有效数/只 | 治愈率/% |
试验数 | 100 | 98 | 2 | 98% |
攻毒组 | 100 | 18 | 10 | / |
空白对照组 | 0 | / | / | / |
由表1可知,本发明的治愈率为98%,治愈效果较好。同时保存容易,易被鸡群所接受。
以上详细描述了本发明的较佳具体实施例。应当理解,本领域的普通技术人员无需创造性劳动就可以根据本发明的构思作出诸多修改和变化。因此,凡本技术领域中技术人员依本发明的构思在现有技术的基础上通过逻辑分析、推理或者有限的实验可以得到的技术方案,皆应在由权利要求书所确定的保护范围内。
Claims (10)
1.一种禽用抗支气管炎病毒的组合物,其特征是:包括黄芪提取物1.2份,人参提取物1.5份、茯苓提取物1.7份,黄芪提取物1.8份,当归提取物1.5份,山药提取物2份,菊花提取物1.8份,淫羊霍提取物1.5份,大青叶提取物1.2份,黄连提取物1.2份,板蓝根提取物1.2份,麻黄提取物1.3份,白芍提取物1.1份,细辛提取物1.2份,五味子提取物1.3份。
2.如权利要求1所述的禽用抗支气管炎病毒的组合物,其特征是:还包括禽用抗病毒卵黄抗体,禽用抗病毒转移因子1.8份和α-干扰素1.2份。
3.如权利要求1所述的禽用抗支气管炎病毒的组合物,其特征是:所述禽用抗病毒卵黄抗体为抗鸡新城疫卵黄抗体,所述禽用抗病毒转移因子为抗鸡新城疫转移因子。
4.一种禽用抗支气管炎病毒的冻干粉,其特征是:主要由以下重量份数的组分组成:黄芪提取物1.2份,人参提取物1.5份、茯苓提取物1.7份,黄芪提取物1.8份,当归提取物1.5份,山药提取物2份,菊花提取物1.8份,淫羊霍提取物1.5份,大青叶提取物1.2份,黄连提取物1.2份,板蓝根提取物1.2份,麻黄提取物1.3份,白芍提取物1.1份,细辛提取物1.2份,五味子提取物1.3份。
5.根据权利要求4所述禽用抗支气管炎病毒的冻干粉,其特征是:还包括以下重量份数的组分:禽用抗病毒卵黄抗体70-80份,禽用抗病毒转移因子1.8份和α-干扰素1.2份。
6.根据权利要求4或5所述的禽用抗支气管炎病毒的冻干粉,其特征是:还包括氨茶碱1.8份。
7.如权要求4或5所述的禽用抗支气管炎病毒的冻干粉,其特征是:包括链霉素1份和以重量份计0.05%的多维生素。
8.一种禽用抗支气管炎病毒的冻干粉制备方法,其特征在于:包括以下步骤:
(1)分离毒株制备疫苗,灭活后制得乳油剂疫苗备用;
(2)中药提取液的制备:按照如权利要求1所述的重量配比,取相同份数的中药材,采用常规水煎制备所述中药材的提取液;
(3)将步骤(2)中的中药材提取液进行浓缩,浓缩至1g/ml的药液;
(4)将步骤(3)中的药液进行3000r/ml进行离心,离心20min,得上清液;
(5)将步骤(4)中的药液用0.22μm进行微孔滤膜过滤,高压蒸汽灭菌,4℃冷藏备用;
(6)免疫健康鸡群制备高免蛋:取步骤(1)制备的疫苗接种健康鸡群,当抗体效价达到1:256时,收集高免蛋清理、消毒后晾干备用;
(7)分离高免蛋卵黄:取步骤(6)制备的高免蛋分离卵黄,加入等体积的无菌水,充分搅拌至颜色发白的卵黄溶液,将卵黄溶液置于60-65℃的水浴中加热20min。再加入PH为4.9-5.2的预冷酸化水,加入量为卵黄溶液体积的6-8倍,混匀后室温下静置沉淀,取得上清液后离心分离;
(8)取步骤(7)离心后的上清液,过滤,使得滤液中禽用抗病毒卵黄抗体的干重为70-80份,在浓缩液中加入步骤(5)的灭菌药液,再加入氨茶碱1.8份,防腐剂0.01份,灭活剂0.2份,链霉素1份,耐热冻干保护剂3份,0.05%的维生素1份,混匀后预冻、冻干备用;
(9)以重量份数剂,在步骤(8)的干粉中加入禽用抗病毒转移因子1.8份和α-干扰素1.2份即可。
9.如权利要求8所述的一种禽用抗支气管炎病毒的冻干粉制备方法,其特征是:所述禽用抗支气管炎病毒转移因子的制备方法为:
(1)取刚屠宰的新鲜健康猪脾,用生理盐水反复冲洗后灭菌并去膜、脂肪、筋等;
(2)组织捣碎机以5000r/min的速度进行捣碎,共3次,每次间隔5min;
(3)冷却捣碎机,冷却后的细胞培养液以1500r/min的速度离心10min;
(4)去除离心液的上清液,续加氯化铵液,离心并去红细胞;
(5)利用小牛血清培养液制成猪脾细胞培养液;
(6)取步骤(5)中的猪脾细胞培养液100μl,加入质量浓度为100g/L的乙肝疫苗100μl;
(7)取步骤(6)中的猪脾细胞培养液,加入质量浓度为20g/L的支气管炎病毒疫苗50μl;
(8)将步骤(7)中的培养液加入蒸馏水1:1稀释,-25℃反复冻融6次,自来水融化后装入透析袋中;
(9)用1:4蒸馏水作为透析外液,4℃透析48h,取得透析液,4℃保存或冻干备用。
10.一种如权利要求4或5所述的一种禽用抗支气管炎病毒冻干粉作为饲料添加剂的应用,其特征是:包括以下步骤,将禽用抗支气管炎病毒冻干粉以1.2%的量加入禽用饲料中即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711292002.2A CN108096416A (zh) | 2017-12-08 | 2017-12-08 | 一种禽用抗支气管炎病毒的组合物、冻干粉及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711292002.2A CN108096416A (zh) | 2017-12-08 | 2017-12-08 | 一种禽用抗支气管炎病毒的组合物、冻干粉及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108096416A true CN108096416A (zh) | 2018-06-01 |
Family
ID=62209366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711292002.2A Withdrawn CN108096416A (zh) | 2017-12-08 | 2017-12-08 | 一种禽用抗支气管炎病毒的组合物、冻干粉及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108096416A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116270866A (zh) * | 2021-12-20 | 2023-06-23 | 洛阳瑞华动物保健品有限公司 | 一种抗病毒口服液的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104208673A (zh) * | 2013-09-30 | 2014-12-17 | 郑州后羿制药有限公司 | 一种禽用抗病毒组合物、冻干粉、制备方法及应用 |
-
2017
- 2017-12-08 CN CN201711292002.2A patent/CN108096416A/zh not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104208673A (zh) * | 2013-09-30 | 2014-12-17 | 郑州后羿制药有限公司 | 一种禽用抗病毒组合物、冻干粉、制备方法及应用 |
Non-Patent Citations (3)
Title |
---|
亓丽红: "中草药防治鸡传染性支气管炎", 《动物医学进展》 * |
杨诗杰: "体外免疫法制备乙肝病毒特异性转移因子的工艺研究", 《广东医学院学报》 * |
谷颖: "10种中药提取物抗传染性支气管炎病毒效果的研究", 《山东畜牧兽医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116270866A (zh) * | 2021-12-20 | 2023-06-23 | 洛阳瑞华动物保健品有限公司 | 一种抗病毒口服液的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101658551A (zh) | 一种抗猪病毒病的金银花组合物 | |
CN105641149B (zh) | 荆防败毒口服液及其制备方法 | |
CN1883610B (zh) | 治疗禽类病毒性疾病的中兽药及其制备方法 | |
CN104285883A (zh) | 一种肉鸡的养殖方法 | |
CN108096416A (zh) | 一种禽用抗支气管炎病毒的组合物、冻干粉及制备方法 | |
CN104288217A (zh) | 一种中药组合物及用途 | |
CN101637519A (zh) | 一种增强畜禽肝肾解毒功能的中药兽药 | |
CN103860656A (zh) | 一种中药组合物及其制备方法和其应用 | |
CN108096523A (zh) | 一种禽用抗肝炎病毒的组合物、制备方法及应用 | |
CN104306934B (zh) | 一种具有增强免疫力的药物组合物及其制备方法 | |
CN104274511A (zh) | 一种兽用中药组合物及其应用 | |
CN104940404A (zh) | 一种防治鸡白痢的制剂及其制备方法 | |
CN108030815A (zh) | 一种禽用抗细小病毒的组合物、冻干粉及制备方法 | |
CN104840591A (zh) | 一种具有防治新城疫功效的中药组合物 | |
CN105853670A (zh) | 一种真性鸡瘟的治疗药物 | |
CN105395835A (zh) | 一种用于家禽育雏期大肠杆菌感染的中药组合物 | |
CN105876236A (zh) | 用于防治鸡传染性鼻炎的饲料添加剂及其制备方法 | |
CN110302326A (zh) | 一种防治鸽毛滴虫病的中草药复方制剂以及制备方法 | |
CN104222505A (zh) | 用于提高仔猪免疫力的饲料 | |
CN103919868A (zh) | 一种治疗大菱鲆淋巴囊肿病的中药组合物 | |
CN105770779A (zh) | 一种防治牛传染性胸膜肺炎的药物组合物及其制备方法 | |
CN106692857A (zh) | 一种治疗马巴贝西焦虫病的中药组合物 | |
CN105901199A (zh) | 一种清热凉茶及其制备方法 | |
CN104222520A (zh) | 用于提高仔猪免疫力的饲料添加剂 | |
CN104971299A (zh) | 抗肿瘤中药组合物、其制备和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180601 |
|
WW01 | Invention patent application withdrawn after publication |